HORIZON EUROPE
Europeo
Specific Challenge:Plant protection and biocidal products (both covered under the term "pesticides") are used in agriculture to secure yield and ensure food and feed safety across agricultural production and the agri-food chain. At the same time, pesticides may have effects on the environment, non-target organisms, animal and human health. In the EU they are regulated[1] and assessed for pre-market approval but tools and methods need to be further developed to better understand the overall risks and impacts associated with their individual and combined use and possible side effects. Member States and EU policies seek to reduce reliance on pesticides by designing and implementing more integrated approaches to the use of pesticides while at the same time safeguarding competitiveness.
Scope:A. [2019]: Integration of plant protection in a global health approach (RIA)
Activities will test and deliver integrated approaches to advance in the assessment of the impacts of plant protection products and their metabolites (PPPs) on plant, human, animal and ecosystem health. Activities will build on existing data, validated models of PPPs fluxes/conce...
ver más
Specific Challenge:Plant protection and biocidal products (both covered under the term "pesticides") are used in agriculture to secure yield and ensure food and feed safety across agricultural production and the agri-food chain. At the same time, pesticides may have effects on the environment, non-target organisms, animal and human health. In the EU they are regulated[1] and assessed for pre-market approval but tools and methods need to be further developed to better understand the overall risks and impacts associated with their individual and combined use and possible side effects. Member States and EU policies seek to reduce reliance on pesticides by designing and implementing more integrated approaches to the use of pesticides while at the same time safeguarding competitiveness.
Scope:A. [2019]: Integration of plant protection in a global health approach (RIA)
Activities will test and deliver integrated approaches to advance in the assessment of the impacts of plant protection products and their metabolites (PPPs) on plant, human, animal and ecosystem health. Activities will build on existing data, validated models of PPPs fluxes/concentrations, models for economic analysis, integrated risk assessment tools, running projects and the European Food Safety Authority's (EFSA) activities. Activities will support new measurements and observations and further develop more comprehensive and reliable models. A synthesis of risks, cost and benefit analysis of PPPs' use at different spatial and temporal scales and their distribution between different stakeholders should be performed (including damages caused by pests, product quality and regulatory costs). Activities will build on representative case studies covering different agricultural products.
In terms of human health, both direct and indirect exposures to PPPs will be taken into account with a particular focus on direct exposure of farmers and the rural population and the exposure of consumers to PPP residues in food. Animal health risk assessment should take into account the exposure to residues of PPPs in feed (aggregating EU uses and residues in imported feed). Work on environmental risks and impacts should consider the diversity of European agricultural landscapes, as well as ecological and environmental variability. It should make it possible to gauge the spatial dimension of impacts and map risks at regional, national, European and global levels while considering other regulatory initiatives, in particular the Common Agricultural Policy, the protection of European biodiversity and the Water Framework Directive.
Proposals will identify lock-ins, develop transition paths towards a sustainable use of PPPs, taking a transdisciplinary approach, and should consider the needs of risk managers for the authorisation/restriction of PPPs as well as of farmers for selecting more appropriate and sustainable products and their optimal use avoiding side effects. Activities will include the development of a research agenda on plant protection in the context of a global health approach.
B. [2020] Alternative to contentious pesticides (IA)
Activities will foster the development and testing of tools, approaches, strategies and/or products to reduce the risks associated with the use of contentious plant protection products and/or biocidal products in conventional and/or organic farming systems and/or the agri-food chain. They will seek for more sustainable alternatives to contentious (or, as appropriate, active substances used in) plant protection product(s) for integrated pest, disease and/or weed management in agriculture and/or biocidal product(s) for preventing and controlling harmful organisms occurring in facilities related to agricultural production and the agri-food chain. Activities should address the development, testing and demonstration of novel, more durable and sustainable approaches, products, strategies and/or tools for their application within a systems approach and cultural practices.
The Commission considers that proposals requesting a contribution from the EU of up to EUR 15 million for scope A and EUR 5 million for scope B would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
All sub-topics (A), (B): Projects should fall under the concept of the ‘multi-actor approach’[2] including a range of actors to ensure that knowledge and needs from various sectors such as research, farming, advisory services and industry including SMEs are brought together. They should also seek contributions from social and economic sciences to cover the broader economic, social, behavioural and environmental issues associated with the adoption of novel management strategies, including the impact on labour, safety culture and risk management on farms and economic impact for farmers. This will include looking at gender aspects, as appropriate.
Expected Impact:Activities will contribute to a better understanding of complex, interlinked issues and reduce the reliance on the use of pesticides by helping to:
establish the impacts of the use or non-use of pesticides on the environment and human health (consumers, operators, farm workers and residents in agricultural areas);improve farmer, consumer and citizen awareness of and trust in global health approaches through clear and transparent and integrated assessments, pest / disease / weed prevention and control strategies for EU agricultural production and / or the agri-food chain and related communication;contribute to the ongoing collection of harmonised EU-wide datasets in open source collaboration and of indicators to assess and monitor trends over time and support risk management measures (scope A);improve monitoring of pesticide uses and pressures on human and animal health and the environment, by developing appropriate tools and integrated approaches considering various pathways (scope A);foster lasting transdisciplinary cooperation in the fields of life sciences, human, plant and animal health and environmental sciences and strengthen the European scientific community on global health approaches (scope A);introduce alternative approaches, tools, strategies and/or products for prevention and control of pests/diseases/weeds with improved environmental performance (e.g. reduced effects on non-target organisms, natural resources and the environment) in the field of plant protection and/or use of biocides related to agricultural production and activities across the agri-food chain (scope B);assess the potential risks and benefits of the chosen alternatives in a coherent and consistent way in view of safety and sustainability (scope B);improve current agronomic, ecological and cultural practices to increase the resilience of agricultural production and/or the agri-food chain against biotic stresses (scope B);assess the economic, social and environmental impact of the alternative proposals for the farmers and/or consumers (scope B);support relevant EU plant health policies and/or European risk assessments in relation to EFSA and / or ECHA activities (scope B). In the longer-term results will strengthen an integrated health approach and foster the sustainable use of pesticides thereby reducing the exposure of human and animals, terrestrial and aquatic ecosystems, drinking water and the food chain to pesticides.
Cross-cutting Priorities:GenderSocio-economic science and humanitiesRRI
[1]Regulations (EC) No 1107/2009 and (EU) No 528/2012
[2]See definition of the 'multi-actor approach' in the introduction of this Work Programme part
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
Information on the outcome of evaluation (two-stage call):
For stage 1: maximum 3 months from the deadline for submission.
For stage 2: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Innovation Action:
Specific provisions and funding rates
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in Annex B and Annex C of the Work Programme.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
Information on the outcome of evaluation (two-stage call):
For stage 1: maximum 3 months from the deadline for submission.
For stage 2: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
Research and Innovation Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
6. Additional provisions:
Horizon 2020 budget flexibility
Classified information
Technology readiness levels (TRL) – where a topic description refers to TRL, these definitions apply
Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.
8. Additional documents:
1. Introduction WP 2018-20
9. Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy WP 2018-20
18. Dissemination, Exploitation and Evaluation WP 2018-20
General annexes to the Work Programme 2018-2020
Legal basis: Horizon 2020 Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.
Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in Annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs. See the Online Manual.
Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta